AbCellera Biologics Inc vs Northrop Grumman Corporation — how do they compare? AbCellera Biologics Inc trades at $8.95 (market cap $2.99B), while Northrop Grumman Corporation trades at $574.85 (market cap $81.78B). The key difference: Northrop Grumman Corporation is far larger — about 27.4× AbCellera Biologics Inc's market cap, and Northrop Grumman Corporation pays a 1.63% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | NOC | |
|---|---|---|
Market Cap | $2.99B | $81.78B |
Sector | Health | Industrials |
52-Week High | $9.76 | $768.02 |
52-Week Low | $2.78 | $496.02 |
Enterprise Value | $2.58B | $95.77B |
Dividend Yield | — | 1.63% |
Trailing returns across standard periods
Latest headlines on both assets
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →Northrop Grumman is a defense contractor that is diversified across short-cycle and long-cycle businesses. The firm's segments include aeronautics, mission systems, defense services, and space systems. The company's aerospace segment creates the fuselage for the massive F-35 program and produces various piloted and autonomous flight systems. Mission systems creates a variety of sensors and processors for defense hardware. The defense systems segment is a long-range missile manufacturer. Finally, the company's space systems segment produces various space structures, sensors, and satellites.
Read more on NOC →